Compare
Alpha Cognition Inc. vs Pelthos Therapeutics Inc. vs Zeo ScientifiX, Inc. vs Scilex Holding Co
| Latest fiscal year | Alpha Cognition Inc. ACOG | Pelthos Therapeutics Inc. PTHS | Zeo ScientifiX, Inc. ZEOX | Scilex Holding Co SCLXRevenue covers only part of its income (partial revenue) |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-10-31 | 2025-12-31 |
| Revenue | $10.22M | $16.80M | $5.20M | $30.25M |
| Revenue growth (YoY) | n/a | n/a | +12.5% | -46.5% |
| Gross margin | 94.1% (computed) | 76.3% (computed) | 82.1% | 65.0% (computed) |
| Operating margin | -221.7% | -193.1% | -103.6% | n/m |
| Net margin | -202.2% | -257.9% | -106.2% | n/m |
| Net income | -$20.67M | -$43.32M | -$5.52M | -$374.05M |
| EPS (Diluted) | -$1.18 | -$23.04 | -$0.86 | -$36.48 |
| Operating cash flow | -$20.38M | -$22.59M | -$718.0K | $3.82M |
| Free cash flow | -$20.67M | -$22.69M | -$741.0K | $3.68M |
| Cash & equivalents | $66.05M | $17.97M | n/a | $4.96M |
| Total assets | $79.73M | $130.40M | $1.53M | $364.98M |
| Total liabilities | $17.20M | $91.52M | $2.95M | $576.73M |
| Shareholders' equity | $62.53M | $38.88M | -$1.42M | -$207.78M |
| Return on year-end equity | -33.1% | -111.4% | n/a | n/a |
| Shares outstanding | 21.74M | 3.23M | 6.75M | 7.03M |
Revenue, most recent five fiscal years
| Fiscal year | Alpha Cognition Inc. | Pelthos Therapeutics Inc. | Zeo ScientifiX, Inc. | Scilex Holding Co |
|---|---|---|---|---|
| Latest | $10.22M Ended 2025-12-31 | $16.80M Ended 2025-12-31 | $5.20M Ended 2025-10-31 | n/a |
| 1 year earlier | n/a | $0 Ended 2024-12-31 | $4.62M Ended 2024-10-31 | n/a |
| 2 years earlier | n/a | n/a | $4.56M Ended 2023-10-31 | n/a |
| 3 years earlier | n/a | n/a | $6.49M Ended 2022-10-31 | n/a |
| 4 years earlier | n/a | n/a | $5.60M Ended 2021-10-31 | n/a |